Skip to content
10-Q

Quarterly Report

VIRPAX PHARMACEUTICALS, INC.

0001731122-24-001812

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 12, 2024 4.89M sh
Shares Diluted Q3 2024 · Sep 30, 2024 4.66M sh
Shares Diluted Q3 2024 · Sep 30, 2024 2.59M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 1.17M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 1.17M sh
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$13.84M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$6.84M
Stockholders Equity Q3 2024 · Sep 30, 2024 −$2.05M
Stockholders Equity Q3 2024 · Jun 30, 2024 −$2.79M
Stockholders Equity Q3 2024 · Mar 31, 2024 −$1.21M
Stockholders Equity Q3 2024 · Dec 31, 2023 $1.93M
Stockholders Equity Q3 2024 · Sep 30, 2023 $6.51M
Stockholders Equity Q3 2024 · Jun 30, 2023 $12.3M
Stockholders Equity Q3 2024 · Mar 31, 2023 $15.2M
Stockholders Equity Q3 2024 · Dec 31, 2022 $16.58M
Current Liabilities Q3 2024 · Sep 30, 2024 $2.36M
Current Liabilities Q3 2024 · Dec 31, 2023 $7.69M
Total Liabilities Q3 2024 · Sep 30, 2024 $2.36M
Total Liabilities Q3 2024 · Dec 31, 2023 $7.69M
Current Assets Q3 2024 · Sep 30, 2024 $304.16K
Current Assets Q3 2024 · Dec 31, 2023 $9.63M
Total Assets Q3 2024 · Sep 30, 2024 $304.16K
Total Assets Q3 2024 · Dec 31, 2023 $9.63M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.43
Eps Diluted Q3 2024 · Sep 30, 2024 −$3.34
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$5.12
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$9.07
Eps Basic Q3 2024 · Sep 30, 2024 −$0.43
Eps Basic Q3 2024 · Sep 30, 2024 −$3.34
Eps Basic restated Q3 2024 · Sep 30, 2023 −$5.12
Eps Basic restated Q3 2024 · Sep 30, 2023 −$9.07
Sga Expense Q3 2024 · Sep 30, 2024 $780.96K
Sga Expense Q3 2024 · Sep 30, 2024 $3.97M
Sga Expense Q3 2024 · Sep 30, 2023 $4.62M
Sga Expense Q3 2024 · Sep 30, 2023 $6.98M
Rd Expense Q3 2024 · Sep 30, 2024 $1.14M
Rd Expense Q3 2024 · Sep 30, 2024 $4.71M
Rd Expense Q3 2024 · Sep 30, 2023 $1.5M
Rd Expense Q3 2024 · Sep 30, 2023 $4.02M
Net Income Q3 2024 · Sep 30, 2024 −$2.01M
Net Income Q3 2024 · Sep 30, 2024 −$8.68M
Net Income Q3 2024 · Jun 30, 2024 −$3.45M
Net Income Q3 2024 · Mar 31, 2024 −$3.22M
Net Income Q3 2024 · Sep 30, 2023 −$5.99M
Net Income Q3 2024 · Sep 30, 2023 −$10.63M
Net Income Q3 2024 · Jun 30, 2023 −$3.11M
Net Income Q3 2024 · Mar 31, 2023 −$1.52M
Operating Income Q3 2024 · Sep 30, 2024 −$1.92M
Operating Income Q3 2024 · Sep 30, 2024 −$8.69M
Operating Income Q3 2024 · Sep 30, 2023 −$6.12M
Operating Income Q3 2024 · Sep 30, 2023 −$11.01M